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Man’s Worst Friend? 
TCDD and Male Reproductive Effects 
Animal studies indicate that 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) and related compounds are reproductive and developmen-
tal toxicants, but effects of human
exposures are unclear. Five months
after the January 1999 accidental con-
tamination of animal feed with poly-
chlorinated biphenyls and TCDD in
Belgium, a research team collected
blood and semen samples from 101
men aged 20 to 40 living in Antwerp
and Peer [EHP 114:1670–1676;
Dhooge et al.]. The resulting analysis
is the first to link exposure to TCDD
and dioxin-like compounds to male
reproductive effects in the general
population.
Blood sample hormone analysis
yielded measurements for total testos-
terone, luteinizing hormone, follicle-
stimulating hormone, sex hormone-
binding globulin, total 17β-estradiol,
and inhibin B. Free testosterone was
calculated from total testosterone and
sex hormone–binding globulin values.
Blood samples were also used to assay
for compounds with the ability to
bind to aryl hydrocarbon receptor,
the target of TCDD; these results were expressed as a TCDD
equivalent (TEQ). Semen analysis included volume, sperm concen-
tration and morphology, and total sperm counts.
Serum TCDD levels increased significantly with age and con-
sumption of eggs, fish, and chicken. Rising TEQ values were associ-
ated with greater sperm concentration
and reduced semen volume and total
testosterone. These results could
indicate that dioxin-like compounds
decrease testosterone levels in the
blood and consequently interfere
with the secretory function of the
seminal vesicles or prostate. The
researchers saw no significant rela-
tionships between TEQ and any of
the other hormone levels or with
total sperm count or morphology.
TEQ was also positively correlated
with egg consumption, a possible
reflection of the food contamination
accident. 
Based on their analyses, the
researchers conclude that TCDD and
other compounds that bind to the
aryl hydrocarbon receptor do not
affect sperm creation. Whether
decreased gland secretion has an
impact on the fertilizing capacity of
the sperm cell cannot be determined
from these results. –Julia R. Barrett
Health on the Factory Floor
Occupational Phthalate Exposure 
Reduces Testosterone
Human studies have shown widespread exposure to phthalates, com-
pounds used in the manufacture of household, consumer, and med-
ical products. The metabolites mono-2-ethylhexyl phthalate
(MEHP) and mono-n-butyl phthalate (MBP) have shown testicu-
lar toxicity in rats, specifically damage to the cells that produce
testosterone and sperm. But animal studies involve higher phthalate
exposures than humans typically experience, and there is inconclu-
sive evidence that low exposures affect testicular cells in men.
Occupational phthalate exposure tends to be greater and more con-
sistent than the highly variable low levels seen in the general popula-
tion, however, and research at a Chinese manufacturing plant now
reveals that such exposure can be significantly related to decreased
blood testosterone concentration [EHP 114:1643–1648; Pan et al.].
The study participants included 74 men who manufactured
polyvinyl chloride (PVC) flooring at a plant in Liaoning Province and
63 men employed at a construction company. All the men completed
a questionnaire about lifestyle factors and provided blood and urine
samples. Blood samples were analyzed for circulating amounts of free
testosterone, luteinizing hormone, follicle-stimulating hormone, and
estradiol. Urine analysis provided data on concentrations of MBP and
MEHP, which served as biomarkers of exposure. 
Due to the materials involved in flooring manufacture, the men at
the flooring plant were assumed to have dermal and inhalational expo-
sure to dibutyl phthalate (DBP) and di-2-ethylhexyl phthalate
(DEHP), the parent compounds of MBP and MEHP. Indeed, all the
participants except one construction worker had detectable levels of
urinary MBP and MEHP, demonstrating that phthalate exposure was
pervasive. However, PVC plant workers had up to 100-fold higher
levels of MBP and MEHP and significantly lower blood testosterone
concentrations, compared with construction workers.
Regression analysis revealed a modest but significant decrease in
testosterone as total phthalate esters increased. Based on MEHP con-
centrations, the investigators estimated that 40.5% of the PVC plant
workers had DEHP exposure exceeding the European Union’s tolera-
ble daily intake standard of 37.0 µg/kg body weight.
The team concluded that high levels of DEHP and DBP exposure
seemed to suppress testosterone production in the PVC plant workers,
but it is not clear from this study what effect, if any, that might have
on their fertility. –Julia R. Barrett
Lowered productivity. Men exposed to phthalates in a PVC flooring
plant showed decreases in testosterone levels.
Breakfast of losers? Men who ate eggs, fish, and chicken follow-
ing a food supply dioxin contamination incident showed decreased
semen volume and testosterone.Science Selections
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Fetal Lead Exposure 
Timing Is Everything for Effects
Many countries have set guidelines for levels of environmental lead
exposure that are considered safe for children. However, relatively
few studies have focused exclusively on the role of prenatal lead
exposure on infant neurodevelopment. Indeed, studies conducted in
the past 20 years have shown inconsistent results, perhaps because of
variability in when prenatal lead was measured (first, second, or third
trimester) and in what type of sample (maternal plasma, maternal
whole blood, or umbilical
cord blood). A comprehen-
sive study published this
month is the first to compare
such variables [EHP 114:
1730–1735; Hu et al.]. 
From 1997 to 1999, the
investigators measured lead
levels of 146 pregnant women
living in Mexico City. Leaded
gasoline was sold in Mexico
City until 1997, and bone
lead levels in women there are
about three times higher than
in the United States. The
leaching of lead stored in a
mother’s bones provides a
major source of fetal lead
exposure. 
The investigators obtained
samples of plasma and whole
blood during each trimester
and umbilical cord blood at delivery. They also tested the neurodevel-
opment of the children at age 24 months using the Mental
Development Index (MDI), which evaluates memory, language, and
sensory abilities. 
The authors found that lead exposure during the first trimester of
pregnancy was more strongly linked to later decreases in the MDI
scores than exposure during the latter two trimesters. Moreover,
maternal plasma lead was the best predictor of a child’s later neurobe-
havioral performance because most of the lead in whole blood is
attached to red cells and cannot cross the placenta. Each increase of
1 standard deviation unit in
plasma lead lowered the MDI
score by 3.5 points. Neither
maternal levels in the second or
third trimester nor cord blood
levels impacted MDI scores in
as strong a fashion.
The results raise two ques-
tions: should lead be routinely
measured in the first trimester
of pregnancy, and are there
ways to reduce fetal exposure?
Plasma lead is expensive and
difficult to measure, according
to the authors, making routine
clinical testing impractical.
Studies suggest that calcium
supplements slow the release of
lead from bone. An ongoing
clinical trial of pregnant women
is assessing the efficacy of this
intervention. –Carol Potera
New Neurons at Risk
Genotoxicants and
Brain Development
Neurodevelopmental disorders such as learn-
ing disabilities, mental retardation, and
autism spectrum disorders affect an esti-
mated 5–10% of the 4 million babies born
in the United States annually. In a report
released in 2000, the National Research
Council concluded that 3% of these disor-
ders are the direct result of environmental
exposures to neurotoxicants, with another
25% arising from the interaction between such exposures and genet-
ic susceptibility. Investigators have shown that many of these long-
term adverse outcomes can be attributed to genetic damage to
immature neurons in the developing brain related to exposure to
genotoxicants, chemicals that disrupt the complex, delicate cellular
process that regulates development of a fully functional brain.
Although the precise mechanisms involved are still poorly under-
stood, scientists are now starting to unravel the molecular ravages
caused by genotoxicants [EHP 114:1703–1712; Kisby et al.].
As reported in this month’s issue, a research group exposed
cultures of immature neurons known as granule cells and the more
developed and more abundant astrocytes to sublethal doses of two
well-characterized alkylating genotoxicants: methylazoxymethanol
(MAM), a highly toxic compound synthesized from the poison found
in plants called cycads, and nitrogen mustard (HN2), a chemothera-
peutic agent. The team then analyzed the cultures for cell viability,
DNA damage, markers of apoptosis, and cor-
responding gene expression patterns. The
intent of the research is ultimately to identify
the key molecular networks that are targeted
by genotoxicants, in order to understand how
such agents influence brain development.
Results showed that granule cells were
much more sensitive to the genotoxicants
than astrocytes. The exposures caused dose-
dependent DNA lesions that persisted and
accumulated, apparently because, unlike
astrocytes, granule cells lack the ability to
repair DNA damage. In other words, once the
exposure has wreaked havoc on the developing neurons, the damage is
done, and its impact is felt throughout the process of neuronal devel-
opment, leading to long-term impairment. The authors speculate that
these events “could explain why the developing cerebellum is a prime
target in several human neurodevelopmental disorders.” 
The team also discovered that the two genotoxicants affected
distinctly different sets and functional types of genes. MAM targeted
differentiation, stress and immune response, cell signaling, and tran-
scriptional regulation genes, whereas HN2 targeted apoptosis and pro-
tein synthesis gene expression. This preferential targeting suggests that
different genotoxicants probably cause completely different effects in
the developing brain. With a significant proportion of neuro-
developmental disabilities thought to stem directly from early expo-
sures to DNA-damaging agents or gene–environment interactions
related to such exposures, further investigation of the molecular net-
works involved in these effects is clearly needed. –Ernie Hood
Young and vulnerable. Immature neurons called
granule cells are more sensitive to genotoxicants. 
Early threat. A study of pregnant women in Mexico City showed that fetal lead
exposure during the first trimester had a greater impact on later neurodevelop-
ment than exposure in other trimesters.